|
Volumn 308, Issue 5728, 2005, Pages 1592-1594
|
Latest advances in understanding preeclampsia
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOMEDICAL ENGINEERING;
FETAL MONITORING;
IMMUNOLOGY;
PATIENT MONITORING;
FETUS;
PLACENTA;
PREECLAMPSIA;
PREGNANCE DISORDER;
DISEASES;
ALPHA TOCOPHEROL;
ANTIOXIDANT;
ASCORBIC ACID;
HLA ANTIGEN;
PREGNANCY;
ANTIGEN RECOGNITION;
CLINICAL FEATURE;
CLINICAL TRIAL;
CYTOKINE PRODUCTION;
GESTATIONAL AGE;
HUMAN;
IMMUNE RESPONSE;
NATURAL KILLER CELL;
NONHUMAN;
PLACENTA;
PREECLAMPSIA;
PREGNANCY;
PRIORITY JOURNAL;
REVIEW;
RISK FACTOR;
SURVIVAL;
T LYMPHOCYTE;
ANIMALS;
FEMALE;
FETAL DEVELOPMENT;
HLA ANTIGENS;
HUMANS;
INFLAMMATION;
KILLER CELLS, NATURAL;
OXIDATIVE STRESS;
PLACENTA;
PLACENTATION;
PRE-ECLAMPSIA;
PREGNANCY;
PROTEINS;
TROPHOBLASTS;
|
EID: 20444409135
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.1111726 Document Type: Review |
Times cited : (2161)
|
References (20)
|